Syndrome of inappropriate antidiuretic hormone secretion is characterised by excessive secretion of antidiuretic hormone (ADH) from the posterior pituitary gland or another source
ADH controls water reabsorption but not the retention of solutes. By increasing water retention, ADH assists in the dilution of the blood - decreasing the concentration of solutes such as sodium
In SIADH there is a lack of an effective negative feedback mechanism - results in continual ADH production, independent of serum osmolarity
This leads to abnormally low serum sodium levels and high urinary sodium levels
Causes of SIADH:
Primary brain injury
Malignancy - small cell cancer releasing ADH
Drugs - carbamazepine, SSRIs and amitriptyline
Infectious - atypical pneumonia
Hypothyroidism
Symptoms of SIADH:
Mild hyponatraemia - nausea, vomiting, headache, anorexia and lethargy
Moderate hyponatraemia - muscle cramps, weakness, confusion and ataxia
Severe hyponatraemia - drowsiness, seizures and coma
Patients with SIADH are typically euvolemic or hypervolaemic - fluid overload and not dehydrated
Signs: pulmonary oedema, peripheral oedema, raised JVP and ascites
Investigations for SIADH:
U&Es - serum sodium low
Plasma osmolality - reduced
TFTs - hypothyroidism a potential cause
Serum cortisol - to rule out addison's disease as a cause of low sodium
The following features must be present for a diagnosis of SIADH to be established:
Hyponatraemia
Low plasma osmolality
Inappropriately elevated urine osmolality (i.e. greater than plasma osmolality)
Urine [Na+] >40 mmol/L despite normal salt intake
Euvolaemia
Normal thyroid and adrenal function
Definitive management of SIADH is to treat the underlying cause
Fluid restriction is a common management strategy to increase sodium
If patients have acute symptomatic hyponatraemia they should receive IV hypertonic saline
If SIADH is suspected, consider a CT TAP and head
CNS causes:
Stroke
SAH
Trauma
Psychosis
Hormonal causes:
Hypothyroidism
Hypopituitarism
Hypothyroidism causes SIADH due to reduced cardiac output and reduced renal blood flow which causes release of ADH
Signs of SIADH:
Seizures
Reduced GCS
Coma
Myoclonus
Ataxia
Hyporeflexia
Asterixis
Rapid increases in plasma sodium may result in osmotic demyelination syndrome - due to a rapid increase in extracellular osmolality. It can cause irreversible neurological damage.
A newer class of drugs termed vaptans (e.g. tolvaptan) are now more commonly used. These vasopressin receptor antagonists are effective but expensive agents.
Those with severe hyponatraemia are at risk of permanent neurological damage due to cerebral oedema, typically seen following a rapid (< 48 hrs) drop in sodium to below 120 mmol/L.